BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts

By Boven E.   Verschraagen M.   Hulscher T.M.   Erkelens C.A.M.   Hausheer F.H.   Pinedo H.M.   van der Vijgh W.J.F.  

European Journal of Cancer, Vol. 38, Iss. 8, 2002-05 ,pp. : 1148-1156

Elsevier

Access to resources Recommend Favorite

A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 99-100

Informa Healthcare

Access to resources Recommend Favorite

Phase I/II Study of Intraperitoneal Floxuridine and Platinums (Cisplatin and/or Carboplatin)

By Muggia F.M.   Jeffers S.   Muderspach L.   Roman L.   Rosales R.   Groshen S.   Safra T.   Morrow C.P.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 290-294

Elsevier

Access to resources Recommend Favorite

Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo

By Donnelly Erling   Kelley Marianne   Rockwell Sara  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 43-50

Springer Publishing Company

Access to resources Recommend Favorite

Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro

By                      

Oncology Reports, Vol. 28, Iss. 6, 2012-01 ,pp. : 2023-2028

Spandidos Publications

Access to resources Recommend Favorite